Rozerem and Ddd - a phase IV clinical study of FDA data

Summary:

Ddd is reported as a side effect among people who take Rozerem (ramelteon), especially for people who are male, 60+ old, also take Seroquel, and have Pain.

The phase IV clinical study analyzes which people have Ddd when taking Rozerem. It is created by eHealthMe based on reports of 7,343 people who have side effects when taking Rozerem from the FDA, and is updated regularly.

What is Rozerem?

Rozerem has active ingredients of ramelteon. It is often used in insomnia. eHealthMe is studying from 7,539 Rozerem users. Check the latest studies of Rozerem.

What is Ddd?

Ddd is found to be associated with 1,309 drugs and 1,420 conditions by eHealthMe. Check the latest studies of Ddd.



On Jul, 21, 2026

7,343 people reported to have side effects when taking Rozerem.
Among them, 15 people (0.2%) have Ddd.

Could Rozerem cause Ddd?

Among these 15 people:

What is the gender of people who have Ddd when taking Rozerem? *

  • female: 26.67 %
  • male: 73.33 %

What is the age of people who have Ddd when taking Rozerem? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 7.69 %
  • 30-39: 0.0 %
  • 40-49: 15.38 %
  • 50-59: 0.0 %
  • 60+: 76.92 %

What are other drugs people take besides Rozerem? *

  1. Lipitor: 10 people, 66.67%
  2. Percocet: 10 people, 66.67%
  3. Zoloft: 10 people, 66.67%
  4. Lexapro: 10 people, 66.67%
  5. Ibuprofen: 10 people, 66.67%
  6. Seroquel: 10 people, 66.67%
  7. Roxicet: 9 people, 60.00%
  8. Prozac: 9 people, 60.00%
  9. Proscar: 9 people, 60.00%
  10. Arimidex: 9 people, 60.00%

What are other side effects people have besides Ddd? *

  1. Stress And Anxiety: 12 people, 80.00%
  2. Hepatic Steatosis (fatty liver disease): 11 people, 73.33%
  3. Back Pain: 11 people, 73.33%
  4. Hypoaesthesia (reduced sense of touch or sensation): 11 people, 73.33%
  5. Memory Loss: 11 people, 73.33%
  6. High Blood Cholesterol: 11 people, 73.33%
  7. Pain In Extremity: 11 people, 73.33%
  8. Fatigue (feeling of tiredness): 10 people, 66.67%
  9. Migraine (headache): 10 people, 66.67%
  10. Joint Pain: 10 people, 66.67%

What are the existing conditions these people have? *

  1. Pain: 10 people, 66.67%
  2. Prostate Cancer: 9 people, 60.00%
  3. Bone Density Abnormal: 9 people, 60.00%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 13.33%
  5. Drowsiness: 2 people, 13.33%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 13.33%
  7. Psychotic Disorder: 1 person, 6.67%
  8. Neuropathy Peripheral (surface nerve damage): 1 person, 6.67%
  9. Nausea (feeling of having an urge to vomit): 1 person, 6.67%
  10. Hair Loss: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Rozerem and have Ddd?

- Check whether Ddd is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rozerem:

Ddd treatments and more:

  • Ddd (19,910 reports)

How severe was Ddd and when was it recovered:

Expand to all the drugs that have ingredients of ramelteon:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rozerem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ddd:

  • Ddd (1,309 drugs)

Browse all the conditions that are associated with Ddd:

  • Ddd (1,420 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramelteon (the active ingredients of Rozerem) and Rozerem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: